#Drug Development
15 articles with this tag
AI Transforms Drug Development
Pharmaceutical companies are increasingly turning to AI to accelerate drug discovery, reduce costs, and bring life-saving medicines to market faster.
AI's 'Industrial Revolution' in Healthcare
Boston Children's Hospital's Dr. Joan LaRovere discusses AI's transformative role in healthcare, emphasizing data diversity and personalized medicine.
TriNetX Speeds Drug Trials With Databricks
TriNetX uses Databricks' AI platform to significantly speed up drug development, cutting trial delays and improving research efficiency.
Stipple Bio Secures New Funding
a16z is investing further in Stipple Bio, a biotech startup developing novel epitope-targeted cancer therapies to overcome current drug limitations.
AlphaFold Protein Prediction Reshapes APAC Research
Biotech's AI Infusion: A Tremendous Opportunity
NRG Therapeutics Secures £50M Series B for ALS, Parkinson's Drugs
NRG Therapeutics secured £50 million in Series B funding, led by SV Health Investors’ Dementia Discovery Fund. This investment will advance mitochondrial-targeting treatments for neurodegenerative diseases. The company aims to transition its pipeline, including lead candidate NRG5051 for ALS and Parkinson's, into...
ArcaScience Secures $7M for AI Drug Development Platform Expansion
The platform transforms biomedical data into actionable benefit-risk insights for drug development.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Zurich-based Mabylon, a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.
ASTRA Therapeutics Raises €8.3M for Precision Animal Parasiticides
Villigen, Switzerland-based ASTRA Therapeutics raised €8.3 million in a Seed funding round.
ASTRA Therapeutics Raises €8.3M for Precision Animal Parasiticides
Villigen, Switzerland-based ASTRA Therapeutics raised €8.3 million in a Seed funding round.
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
Upstream Bio IPOs at $830M Valuation, Raises $255M, Advances Respiratory Treatments
